Evidence map›Paper›PMID 41994285›Full record

ArticleFrontiers in microbiology2026

Antimicrobial use on

Quentin Jehanne, Anne Conrad, Raphaële Nove Josserand, Nicolas Benech, Paul Marie Schatz, Lucie Bénéjat, Astrid Ducournau, Johanna Aptel, Moeava Martin, Marine Jauvain and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Quentin JehanneCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Anne ConradHospices Civils De Lyon, Service Des Maladies Infectieuses Et Tropicales, Lyon, France.
Raphaële Nove JosserandHospices Civils De Lyon, Service De Médecine Interne Et Pathologie Vasculaire, Lyon, France.
Nicolas BenechHospices Civils De Lyon, Service D'Hépatogastroentérologie, Lyon, France.
Paul Marie SchatzHospices Civils De Lyon, Service Des Maladies Infectieuses Et Tropicales, Lyon, France.
Lucie BénéjatCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Astrid DucournauCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Johanna AptelCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Moeava MartinCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Marine JauvainCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.
Olivier DauwalderHospices Civils De Lyon, Centre de Biologie et de Pathologie Nord, Institut des Agents Infectieux, Plateau de Microbiologie 24/24, Lyon, France.
Philippe LehoursCHU de Bordeaux, CNR des Campylobacters et des Hélicobacters, Bordeaux, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Because few studies have focused on recurrent

Indexed as

bacteremiaCampylobactercarbapenem resistanceimmunodeficiencynext-generation sequencing

Identifiers

PMID41994285
PMCPMC13079058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.